| 臺大學術典藏 |
2022-05-13T08:04:22Z |
Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015
|
Chiu S.-K.; Ma L.; Chan M.-C.; Lin Y.-T.; Fung C.-P.; Wu T.-L.; Chuang Y.-C.; Lu P.-L.; JANN-TAY WANG; Lin J.-C.; Yeh K.-M. |
| 臺大學術典藏 |
2022-05-13T08:04:20Z |
Appropriate Treatment for Bloodstream Infections Due to Carbapenem-Resistant Klebsiella pneumoniae and Escherichia coli: A Nationwide Multicenter Study in Taiwan
|
Lin Y.-T.; Su C.-F.; Chuang C.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG; Chuang Y.-C.; Siu L.K.; Fung C.-P. |
| 臺大學術典藏 |
2022-05-13T08:04:11Z |
Does antimicrobial therapy affect mortality of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria? A nationwide multicenter study in Taiwan
|
Chuang C.; Su C.-F.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG; Chuang Y.-C.; Kristopher Siu L.; Fung C.-P.; Lin Y.-T. |
| 臺大學術典藏 |
2021-08-20T08:50:17Z |
Clinical significance of Blastocystis hominis: Experience from a medical center in northern Taiwan
|
HAN-YUEH KUO; Chiang D.-H.; Wang C.-C.; Chen T.-L.; Fung C.-P.; Lin C.-P.; Cho W.-L.; Liu C.-Y. |
| 臺大學術典藏 |
2021-08-16T08:36:24Z |
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
|
ARISTINE CHENG; Fung C.-P.; Liu C.-C.; Lin Y.-T.; Tsai H.-Y.; Chang S.-C.; Chou A.-H.; Chang J.-Y.; Jiang R.-H.; Hsieh Y.-C.; Su I.-J.; Chong P.C.S.; Hsieh S.-M. |
| 臺大學術典藏 |
2021-05-06T01:52:04Z |
Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012�V2013
|
Huang S.-H.; YEE-CHUN CHEN; Chuang Y.-C.; Chiu S.-K.; Fung C.-P.; Lu P.-L.; Wang L.-S.; Wu T.-L.; Wang J.-T. |
| 臺大學術典藏 |
2021-04-20T03:46:18Z |
Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis
|
Wu K.-M.; Li N.-H.; Yan J.-J.; Tsao N.; Liao T.-L.; Tsai H.-C.; Fung C.-P.; Chen H.-J.; Liu Y.-M.; Wang J.-T.; CHI-TAI FANG; Chang S.-C.; Shu H.-Y.; Liu T.-T.; Chen Y.-T.; Shiau Y.-R.; Lauderdale T.-L.; Su I.-J.; Kirby R.; Tsai S.-F. |
| 臺大學術典藏 |
2020-12-29T06:37:49Z |
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
|
SZU-MIN HSIEH; Su I.-J.; Chong P.C.S.; Hsieh Y.-C.; Jiang R.-H.; Chang J.-Y.; Chou A.-H.; Chang S.-C.; Tsai H.-Y.; Liu C.-C.; Lin Y.-T.; Cheng A.; Fung C.-P. |
| 臺大學術典藏 |
2020-12-29T06:37:46Z |
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers
|
Liu C.-C.; Chou A.-H.; Chang J.-Y.; Jiang R.; Hsieh Y.-C.; Tsao A.; Wu C.-L.; Huang J.-L.; Fung C.-P.; SZU-MIN HSIEH; Wang Y.-F.; Wang J.-R.; Hu M.-H.; Chiang J.-R.; Su I.-J.; Chong P.C.-S. |
| 臺大學術典藏 |
2020-12-29T05:33:47Z |
Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections
|
Chi C.-Y.;Lin C.-H.;Ho M.-W.;Ding J.-Y.;Huang W.-C.;Shih H.-P.;Yeh C.-F.;Fung C.-P.;Hsin-Yun Sun;Huang C.-T.;Wu T.-S.;Chang C.-Y.;Liu Y.-M.;Feng J.-Y.;Wu W.-K.;Wang L.-S.;Tsai C.-H.;Ho C.-M.;Lin H.-S.;Chen H.-J.;Lin P.-C.;Liao W.-C.;Chen W.-T.;Lo C.-C.;Wang S.-Y.;Kuo C.-Y.;Lee C.-H.;Ku C.-L.; Wang L.-S.; Feng J.-Y.; Wu W.-K.; Liu Y.-M.; Chang C.-Y.; Wu T.-S.; Huang C.-T.; HSIN-YUN SUN; Chi C.-Y.; Lin C.-H.; Ho M.-W.; Ding J.-Y.; Huang W.-C.; Shih H.-P.; Yeh C.-F.; Fung C.-P.; Ku C.-L.; Lee C.-H.; Kuo C.-Y.; Wang S.-Y.; Tsai C.-H.; Ho C.-M.; Lin H.-S.; Chen H.-J.; Lin P.-C.; Liao W.-C.; Chen W.-T.; Lo C.-C. |
